Tenax Therapeutics, Inc. · NASDAQ:TENX

Raymond Debbane's stake in Tenax Therapeutics, Inc. fell to 2.50% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 4, 2026

Raymond Debbane's stake in Tenax Therapeutics, Inc. fell to 2.50%, 427,141 shares, as a passive investor on Mar 31, 2026. Filed May 4, 2026 (Schedule 13G/A).

Stake
2.50%
Shares
427,141
Intent
Passive
What changed
Fell below 5%
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.2.10%366,143
Invus Public Equities Advisors, LLC2.10%366,143
Invus Global Management, LLC2.10%366,143
Siren, L.L.C.2.10%366,143
Avicenna Life Sci Master Fund LP0.40%60,998
Avicenna Life Sci Master GP LLC0.40%60,998
Ulys, L.L.C.0.40%60,998
Raymond Debbane2.50%427,141

Source

View original at SEC

Related